View Older Stories View More Recent Stories

Jan 6, 2015 01:09PM Unusual 11 Mid-Day Movers 1/6: (MOC) (TNXP) (FRO) Higher; (HGG) (CHOP) (CLDN) Lower

Jan 6, 2015 07:09AM Roth Capital Starts Ellie Mae (ELLI) at Buy

Jan 5, 2015 11:57AM Roth Comments on Pharmacyclics (PCYC) Following Publication on New Imbruvica Data

Jan 5, 2015 11:20AM Roth Capital Updates on Investment Thesis Behind Cytokinetics (CYTK)

Jan 5, 2015 10:41AM Notable Analyst Rating Changes 1/5: (LULU) (SKUL) (INTC) Upgraded; (SKH) (SBUX) (CVC) Downgraded

Jan 5, 2015 09:55AM Notable Mergers and Acquisitions 1/5: (UUUU)/(URZ) (BDC) (DDD) (PFE)

Jan 5, 2015 07:24AM Roth Capital Starts Trecora Resources (TREC) at Buy

Jan 5, 2015 07:13AM Roth Capital Starts Pacific Ethanol (PEIX) at Buy

Jan 5, 2015 07:04AM Roth Capital Starts Green Plains (GPRE) at Buy

Jan 5, 2015 07:02AM Energy Fuels, Inc. (UUUU) to Acquire Uranerz Energy (URZ)

Jan 5, 2015 06:56AM Roth Capital Starts Escalade (ESCA) at Buy

Jan 5, 2015 06:37AM Roth Capital Starts Agios Pharma (AGIO) at Neutral

Dec 31, 2014 01:00PM Unusual 11 Mid-Day Movers 12/31: (NRX) (RDHL) (REN) Higher; (NDRM) (CJJD) (DRAM) Lower

Dec 31, 2014 09:24AM Pre-Open Stock Movers 12/31: (NRX) (RDHL) (MIG) Higher; (NDRM) (GSAT) Lower (more...)

Dec 31, 2014 07:48AM Roth Boosts PT on Cytokinetics (CYTK) to $18; Validation of Partnering Ability is Encouraging

Dec 31, 2014 07:05AM S&W Seed (SANW) Enters $31.7M Conv. Debt, Warrants Private Placement

Dec 30, 2014 05:11PM xG Technology (XGTI) Amends Equity Distribution Agreement with Roth Capital

Dec 29, 2014 08:22AM Roth Capital Lowers PT on Can-Fite BioPharma (CANF) to $20; CF101 Remains Key Catalyst

Dec 29, 2014 07:55AM Bluebird Bio (BLUE) Price Target Raised to $120 at Roth

Dec 26, 2014 02:43PM Roth Positive on Spectrum Pharma (SPPI) Following CE-Melphalan NDA Filing (LGND)

Dec 24, 2014 08:52AM Roth 'Encouraged' by Progress, Biz Development of BioLineRx's (BLRX) BL-5010; Affirms 'Buy' Rating

Dec 23, 2014 02:16PM Keryx Biopharma's (KERX) U.S. Launch of AURYXIA Follows Robust Development Program; Roth Affirms 'Buy' Rating

Dec 23, 2014 02:05PM Roth Affirms Cytokinetics (CYTK) at 'Buy'; Astellas Collaboration Development is Encouraging

Dec 22, 2014 07:07AM Roth Capital Starts Energous Corp (WATT) at Buy

Dec 19, 2014 02:29PM Roth Comments on Ligand Pharma (LGND) Following EU Marketing Authorization of Duavive

Dec 19, 2014 09:51AM Roth Affirms Cytori Therapeutics (CYTX) at 'Buy'; BARDA Affirms Strong Support for Thermal Burn Cell Therapy

Dec 18, 2014 12:25PM LED Lamp sales at Staples.com Will be 'Incremental Positive' for Revolution Lighting (RVLT) - Roth Capital

Dec 18, 2014 10:52AM Roth Capital 'Favorable' on Curis' (CRIS) CUDC-907 Following Phase 1 Initiation in a/r Solid Tumors

Dec 18, 2014 07:22AM Roth Capital Downgrades Volcano Corp. (VOLC) to Neutral

Dec 17, 2014 05:00PM MEI Pharma (MEIP) Completes 10M Common Offering

Dec 17, 2014 09:15AM New DoC Antidumping Tariffs Worse-than-Expected for Most Chinese Producers - Roth (TSL) (JASO) (SCTY)

Dec 17, 2014 06:56AM Roth Capital Starts Barracuda Networks (CUDA) at Buy

Dec 16, 2014 07:20AM Roth Capital Still Positive on Celldex (CLDX) Upon Completion of Phase III ACT IV Enrollment

Dec 15, 2014 04:01PM bluebird bio (BLUE) Reports $150M Stock Offering

Dec 15, 2014 08:27AM Roth Capital Lifts PT on BioLineRx (BLRX) to $10.50 Following Investor Day; BL-8040 in AML Remains Promising

Dec 15, 2014 06:42AM Roth Capital Upgrades Sunesis Pharmaceuticals Inc. (SNSS) to Buy

Dec 12, 2014 03:33PM Roth Keeps BioLineRx (BLRX) at 'Buy'; Sees BL-8040 Plan Progressing Nicely Following Recent Update

Dec 12, 2014 02:58PM Notable 52-Week Highs and Lows 12/12: (ADBE) (MACK) (BLUE) High; (EOX) (RSH) (MCP) Low

Dec 12, 2014 02:23PM Roth Affirms Synta Pharma (SNTA) at 'Buy'; Early Ganetespib Data is 'Encouraging'

Dec 12, 2014 08:45AM Roth Remains Positive on Canadian Solar (CSIQ) Following Investor Meetings; Maintains 'Buy' Rating

Dec 12, 2014 08:40AM MEI Pharma (MEIP) Prices 10M Share Offering at $4/Share

Dec 11, 2014 09:58AM Roth Afirms Peregrine Pharma (PPHM) at Buy Following Q2 Numbers; Looking to Data-Heavy 2015

Dec 10, 2014 10:58AM Roth Boosts PT on TG Therapeutics (TGTX) to $33 on Strong ASH Showing, Buyout Prospects

Dec 10, 2014 09:31AM Pre-Open Stock Movers 12/10: (SNSS) (RVLT) (COST) Higher; (GDP) (ALLT) (YUM) Lower (more...)

Dec 10, 2014 08:48AM Energous (WATT) 2.86M Offering Prices at $7/Share

Dec 10, 2014 08:41AM Roth Remains Cautious on Sunesis Pharma (SNSS) Pending FDA Visibility on VALOR

Dec 10, 2014 08:11AM Roth Capital Starts Energy Focus (EFOI) at Buy

Dec 10, 2014 08:10AM Roth Capital Starts Revolution Lighting Technologies (RVLT) at Buy

Dec 9, 2014 12:39PM Pharmacyclics (PCYC) Impresses at ASH; KOLs Excited About Prospects for Imbruvica - Roth Capital

Dec 9, 2014 07:08AM Roth Capital Starts Neuroderm Ltd (NDRM) at Buy

View More Recent Stories View Older Stories